
Drug Eluting Stent Global Market Report 2025
Description
Drug Eluting Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drug eluting stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for drug eluting stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting stent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product: Polymer-Based; Polymer-Free
2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
4) By Application: Coronary Diseases; Peripheral Vascular Diseases
5) By End-User: Hospitals; Specialty Clinic
Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents; Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating; Other Polymer-Free Drug-Eluting Stents
Companies Mentioned: Johnson & Johnson Services Inc.; Abbott; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on drug eluting stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drug eluting stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting stent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product: Polymer-Based; Polymer-Free
2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
4) By Application: Coronary Diseases; Peripheral Vascular Diseases
5) By End-User: Hospitals; Specialty Clinic
Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents; Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating; Other Polymer-Free Drug-Eluting Stents
Companies Mentioned: Johnson & Johnson Services Inc.; Abbott; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Drug Eluting Stent Market Characteristics
- 3. Drug Eluting Stent Market Trends And Strategies
- 4. Drug Eluting Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Drug Eluting Stent Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drug Eluting Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drug Eluting Stent Market Growth Rate Analysis
- 5.4. Global Drug Eluting Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drug Eluting Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drug Eluting Stent Total Addressable Market (TAM)
- 6. Drug Eluting Stent Market Segmentation
- 6.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polymer-Based
- Polymer-Free
- 6.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Other Drugs
- 6.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Biodegradable
- Other Scaffolds
- 6.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Coronary Diseases
- Peripheral Vascular Diseases
- 6.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinic
- 6.6. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Durable Polymer Drug-Eluting Stents
- Biodegradable Polymer Drug-Eluting Stents
- 6.7. Global Drug Eluting Stent Market, Sub-Segmentation Of Polymer-Free, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bare-Metal Stents With Drug Coating
- Other Polymer-Free Drug-Eluting Stents
- 7. Drug Eluting Stent Market Regional And Country Analysis
- 7.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Drug Eluting Stent Market
- 8.1. Asia-Pacific Drug Eluting Stent Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Drug Eluting Stent Market
- 9.1. China Drug Eluting Stent Market Overview
- 9.2. China Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Drug Eluting Stent Market
- 10.1. India Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Drug Eluting Stent Market
- 11.1. Japan Drug Eluting Stent Market Overview
- 11.2. Japan Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Drug Eluting Stent Market
- 12.1. Australia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Drug Eluting Stent Market
- 13.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Drug Eluting Stent Market
- 14.1. South Korea Drug Eluting Stent Market Overview
- 14.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Drug Eluting Stent Market
- 15.1. Western Europe Drug Eluting Stent Market Overview
- 15.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Drug Eluting Stent Market
- 16.1. UK Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Drug Eluting Stent Market
- 17.1. Germany Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Drug Eluting Stent Market
- 18.1. France Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Drug Eluting Stent Market
- 19.1. Italy Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Drug Eluting Stent Market
- 20.1. Spain Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Drug Eluting Stent Market
- 21.1. Eastern Europe Drug Eluting Stent Market Overview
- 21.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Drug Eluting Stent Market
- 22.1. Russia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Drug Eluting Stent Market
- 23.1. North America Drug Eluting Stent Market Overview
- 23.2. North America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Drug Eluting Stent Market
- 24.1. USA Drug Eluting Stent Market Overview
- 24.2. USA Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Drug Eluting Stent Market
- 25.1. Canada Drug Eluting Stent Market Overview
- 25.2. Canada Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Drug Eluting Stent Market
- 26.1. South America Drug Eluting Stent Market Overview
- 26.2. South America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Drug Eluting Stent Market
- 27.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Drug Eluting Stent Market
- 28.1. Middle East Drug Eluting Stent Market Overview
- 28.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Drug Eluting Stent Market
- 29.1. Africa Drug Eluting Stent Market Overview
- 29.2. Africa Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Drug Eluting Stent Market Competitive Landscape And Company Profiles
- 30.1. Drug Eluting Stent Market Competitive Landscape
- 30.2. Drug Eluting Stent Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- 31. Drug Eluting Stent Market Other Major And Innovative Companies
- 31.1. InspireMD Inc.
- 31.2. B. Braun Melsungen AG
- 31.3. Cook Group Incorporated
- 31.4. Lepu Medical Technology (Beijing) Co. Ltd.
- 31.5. Biotronik
- 31.6. Meril Life Sciences Pvt. Ltd.
- 31.7. MicroPort Scientific Corporation
- 31.8. Biosensors International Group Ltd.
- 31.9. OrbusNeich Medical Company Limited
- 31.10. Alvimedica Medical Technologies
- 31.11. Hexacath
- 31.12. Elixir Medical Corporation
- 31.13. Translumina GmbH
- 31.14. Cardionovum GmbH
- 31.15. QualiMed Innovative Medizinprodukte GmbH
- 32. Global Drug Eluting Stent Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Drug Eluting Stent Market
- 34. Recent Developments In The Drug Eluting Stent Market
- 35. Drug Eluting Stent Market High Potential Countries, Segments and Strategies
- 35.1 Drug Eluting Stent Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drug Eluting Stent Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drug Eluting Stent Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.